Microsoft Corporation (MSFT.US) terminates exclusive sales rights of OpenAI model, capital markets reaction is flat
Microsoft and OpenAI have agreed to cancel Microsoft's exclusive sales rights to the OpenAI model. This adjustment will open the door for developers of ChatGPT to collaborate with competitors in cloud computing such as Amazon.
Microsoft Corporation (MSFT.US) has agreed to cancel its exclusive sales rights to the OpenAI model, opening the door for the developers of ChatGPT and competitors in cloud computing such as Amazon.com, Inc. (AMZN.US) to collaborate. This adjustment also marks a new phase in the relationship between the two parties.
According to a joint statement from the two companies on Monday, as part of the exchange to terminate the exclusive arrangement, Microsoft Corporation will no longer pay revenue share on OpenAI products resold through its cloud platform. This revised agreement aims to simplify the long-standing complex relationship between the two parties, while providing greater flexibility to explore new business opportunities.
It is widely believed that this move means the OpenAI model will officially appear on other cloud service platforms such as Amazon.com, Inc. cloud technology, rather than being exclusively sold by Microsoft Corporation. Previously, this exclusivity helped Microsoft Corporation drive cloud business growth in the early days of the AI wave and strengthen its competitive advantage in Azure cloud services.
The two parties stated in the declaration that the revised agreement enhances the predictability of their cooperation and helps them continue to build and operate AI platforms on a large scale, while leaving room to pursue new growth opportunities.
This agreement adjustment is also seen as further implementation of OpenAI's multi-cloud strategy. With a rapid increase in model training and inference demands in recent years, OpenAI has been seeking to collaborate with multiple cloud service providers to meet its computational requirements. As part of an investment agreement announced earlier this year, Amazon.com, Inc. cloud technology (AWS) has stated that it is jointly developing products hosted on AWS with OpenAI.
It is worth noting that, according to previous media reports, Microsoft Corporation had considered taking legal action, believing that the collaboration might violate its exclusive rights to OpenAI's intellectual property. With the new agreement reached, potential disputes have been resolved.
However, Microsoft Corporation still retains a core strategic position. Under the agreement, Microsoft Corporation will remain the "primary cloud services provider" for OpenAI, and new OpenAI products will continue to debut on the Azure platform. In addition, there will be a limit on the revenue share that OpenAI pays to Microsoft Corporation for independently selling products.
Analysts point out that this adjustment reflects a shift in the cooperation between the two parties from "exclusive binding" to a more open model. As OpenAI transitions from a laboratory to a global AI platform company, its business model and infrastructure layout are becoming increasingly difficult to rely on a single partner.
The changes in the relationship between the two parties are also related to OpenAI's restructuring last year. As OpenAI transitioned to a for-profit enterprise, Microsoft Corporation gained a 27% stake in the company, further solidifying the capital ties between the two parties.
Market reaction has been relatively subdued. After the opening of the New York Stock Exchange on Monday, Microsoft Corporation's stock price fell by about 1% at one point, and as of the time of writing, the stock's decline had narrowed to 0.18%, while Amazon.com, Inc. fell by less than 1%.
Related Articles

J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.






